WIRE — The quarter included a provision of Rs 240 crore towards inventory and other associated costs related to Semaglutide API.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.